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Abstract
Background: Trypanosoma brucei is the causative agent of African Sleeping Sickness in humans and contributes to the
related veterinary disease, Nagana. T. brucei is segregated into three subspecies based on host specificity, geography and
pathology. T. b. brucei is limited to animals (excluding some primates) throughout sub-Saharan Africa and is non-infective to
humans due to trypanolytic factors found in human serum. T. b. gambiense and T. b. rhodesiense are human infective sub-
species. T. b. gambiense is the more prevalent human, causing over 97% of human cases. Study of T. b. gambiense is
complicated in that there are two distinct groups delineated by genetics and phenotype. The relationships between the two
groups and local T. b. brucei are unclear and may have a bearing on the evolution of the human infectivity traits.
Methodology/Principal Findings: A collection of sympatric T. brucei isolates from Coˆte d’Ivoire, consisting of T. b. brucei and
both groups of T. b. gambiense have previously been categorized by isoenzymes, RFLPs and Blood Incubation Infectivity
Tests. These samples were further characterized using the group 1 specific marker, TgSGP, and seven microsatellites. The
relationships between the T. b. brucei and T. b. gambiense isolates were determined using principal components analysis,
neighbor-joining phylogenetics, STRUCTURE, FST, Hardy-Weinberg equilibrium and linkage disequilibrium.
Conclusions/Significance: Group 1 T. b. gambiense form a clonal genetic group, distinct from group 2 and T. b. brucei,
whereas group 2 T. b. gambiense are genetically indistinguishable from local T. b. brucei. There is strong evidence for mating
within and between group 2 T. b. gambiense and T. b. brucei. We found no evidence to support the hypothesis that group 2
T. b. gambiense are hybrids of group 1 and T. b. brucei, suggesting that human infectivity has evolved independently in
groups 1 and 2 T. b. gambiense.
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Introduction
The parasite Trypanosoma brucei is the causative agent of African
Sleeping Sickness in humans and one of several pathogens that
cause the veterinary disease Nagana. These diseases have a wide
distribution across sub-Saharan Africa and affect some of the
poorest areas of the world. T. brucei is traditionally segregated into
three morphologically identical sub-species based on host,
geography and pathology. T. b. brucei is limited to domestic and
wild animals throughout sub-Saharan Africa and is non-infective
to humans (and some primates) due to sensitivity to trypanosome
lytic factors found in their serum [1]. T. b. gambiense and T. b.
rhodesiense are human infective sub-species, named due to their
relative geographic locations. While T. b. rhodesiense can infect
humans due to possession of a serum resistance associated (SRA)
gene [2], this gene is not present in the more prevalent West and
central African trypanosome subspecies, T. b. gambiense [3–5],
causative agent of over 95% of reported cases of sleeping sickness
[6,7]. How this sub-species is able to resist lysis by human
trypanolytic factors is still unknown, although there is a decrease in
uptake of lytic factor due to modification of the HpHbR cell
surface receptor that contributes to resistance [8–12]. The study of
T. b. gambiense is complicated in that there are two distinct groups
within the sub-species that can be delineated by genetics and
several phenotypic characteristics [13]. Group 1 T. b. gambiense
causes a chronic infection, is invariably resistant to human serum
and is by far the more prevalent group of the two. It appears to be
largely a disease limited to humans, although some animal
reservoirs have been described [14–19]. Conversely, group 2 T.
b. gambiense are reported to be more virulent and exhibit a variable
human serum resistance mechanism in a manner similar to T. b.
rhodesiense [16,19]. Unlike group 1 T. b. gambiense, group 2 T. b.
gambiense does not possess the modification to the cell surface
receptor HpHbR to avoid lysis by human serum and appears to
utilize a different method to counter lytic factors that is distinct
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from group 1 T. b. gambiense or T. b. rhodesiense [20]. This group of
T. b. gambiense has only been described in Coˆte d’Ivoire, Cameroon
and Burkina Faso to date, and always in geographical areas where
group 1 T. b. gambiense is also found [13,21]. This geographical
overlap of the two groups of T. b. gambiense raises interesting
questions as to whether they share a close genetic relationship and
possibly the ability to undergo sexual recombination.
Investigation of the population genetics of T. b. gambiense would
reveal if such a relationship exists, however most research on T. b.
gambiense field populations has focused on the more prevalent
group 1. Studies with isoenzymes and RFLPs have indicated that
group 1 T. b. gambiense populations exhibit low genetic variation
and appear distinct from T. b. brucei populations [16,19,21–26]
and recent comprehensive microsatellite genotyping techniques
appear to have confirmed this for some populations [27,28]. This
is in contrast to high genetic variation found in T. b. brucei
populations [16,19,22–26,29]. It has also been shown that while
group 1 T. b. gambiense are clonal within a disease focus, there are
genetic differences between isolates from different geographic
locations [27]. During the decades of investigation into the
population structure of T. brucei, a second group of human
infective T. b. gambiense from Coˆte d’Ivoire and Burkina Faso
(formally Upper Volta) were identified that possess different
isoenzyme and RFLP profiles from the classical group 1 T. b.
gambiense isolates. These isolates also showed greater genetic
variation and appeared more similar to local T. b. brucei [16,19,22–
26,30]. The greater variation in genetic markers and similarity to
the T. b. brucei population suggested that this second group of T. b.
gambiense might be genetically competent, in contrast to group 1.
This has subsequently been confirmed by laboratory crosses
between T. b. gambiense group 2 and both T. b. brucei and T. b.
rhodesiense strains [31–33]. The possibility that different mating
structures may exist in the two groups of T. b. gambiense has
implications in evaluating the relationships between them and the
evolution of several traits in the population, including human
infectivity. It is possible that this trait has evolved twice in separate
populations of T. b. gambiense or conversely evolved once but due to
mating events has become invariant in group 1 and variable in
group 2 T. b. gambiense.
A recent study of microsatellite multi-locus genotypes from
many T. brucei isolates from across Africa has found that group 1 T.
b. gambiense form a clade separate from T. b. brucei, T. b. rhodesiense
and group 2 T. b. gambiense [29]. Group 2 T. b gambiense individuals
formed a cluster positioned between T. b. brucei and group 1 T. b.
gambiense, suggesting that group 2 T. b. gambiense may be a hybrid of
group 1 and T. b. brucei and would perhaps share a mechanism for
human infectivity. However, the T. b. brucei used in the study were
mostly from East Africa and are not representative of West African
T. b. brucei that are sympatric with the two T. b. gambiense groups. In
order to resolve the relationships between the two groups of T. b
gambiense and local T. b. brucei, we used a microsatellite genotyping
approach to examine a collection of T. brucei isolates from Coˆte
d’Ivoire [15,16,34]. The isolates have been characterized by the
Blood Incubation Infectivity Test (BIIT) [35,36] and defined as
Table 1. Details of the isolates used in the study, including
the isolate name, the host each strain was isolated from, the
serum resistance profile resulting from a 5 rodent BIIT
(R = highly resistant, I = intermediate or sub-resistant and
S = sensitive) and the geographic location of the isolate when
collected within Coˆte d’Ivoire.
Isolate Name Host
Serum
Resistance Location
MHOM/CI/78/TH112 Human S Bouafle
MHOM/CI/78/TH114 Human R Bouafle
MHOM/CI/78/TH126 Human I Bouafle
MSUS/CI/78/TSW065 Pig S Bouafle
MSUS/CI/78/TSW100 Pig I Bouafle
MSUS/CI/78/TSW113 Pig I Bouafle
MSUS/CI/78/TSW115A Pig R Bouafle
MSUS/CI/78/TSW168 Pig I Bouafle
MSUS/CI/78/TSW175 Pig R Bouafle
MSUS/CI/78/TSW178 Pig S Bouafle
MSUS/CI/78/TSW18 Pig I Bouafle
MSUS/CI/78/TSW182 Pig I Bouafle
MSUS/CI/78/TSW19 Pig I Bouafle
MSUS/CI/78/TSW190 Pig I Bouafle
MSUS/CI/78/TSW196 Pig S Bouafle
MSUS/CI/78/TSW209 Pig I Bouafle
MSUS/CI/78/TSW251 Pig S Bouafle
MSUS/CI/78/TSW308 Pig I Bouafle
MSUS/CI/78/TSW332 Pig S Bouafle
MSUS/CI/78/TSW38 Pig S Bouafle
MSUS/CI/78/TSW390 Pig S Bouafle
MSUS/CI/78/TSW65 Pig S Bouafle
MSUS/CI/78/TSW77 Pig I Bouafle
MHOM/83/DAL587 Human R Bouafle
MHOM/83/DAL598 Human R Daloa
MHOM/83/DAL642 Human R Daloa
MHOM/83/DAL645 Human R Daloa
MHOM/83/DAL403 Human R Daloa
MHOM/83/DAL633 Human R Daloa
MHOM/CI/86/DAL972 Human R Daloa
MHOM/CI/82/DAL654 Human R Daloa
MHOM/CI/83/DAL596 Human R Daloa
MHOM/CI/83/DAL607 Human R Daloa
MHOM/CI/78/DAL069 Human R Daloa
MHOM/CI/78/
DAL072A
Human R Daloa
MHOM/83/DAL595 Human R Gagnoa
MHOM/CI/83/DAL543 Human R Vavoua
MHOM/CI/78/TH1 Human S Vavoua
MSUS/CI/78/TSW155 Pig S Vavoua
MSUS/CI/78/TSW158 Pig I Vavoua
MSUS/CI/78/TSW187 Pig I Vavoua
MHOM/83/DAL542 Human R Vavoua
MHOM/84/DAL740 Human R Vavoua
MHOM/CI/82/DAL494 Human R Vavoua
Table 1. Cont.
Isolate Name Host
Serum
Resistance Location
MHOM/CI/52/ELIANE Human R Coˆte d’Ivoire
doi:10.1371/journal.pone.0067852.t001
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Figure 1. Genetic analysis of the Trypanosoma brucei population at the Coˆte d’ivoire focus. a. Dendrogram of multi-locus genotypes (MLG)
for the T. brucei isolates collected from several townships in Coˆte d’Ivoire, over the period of time 1978–1983 in addition to DAL972 and ELIANE.
Bootstrap values from 100 iterations are indicated for branch nodes with a bootstrap value above 10. The presence of TgSGP using primers spanning
the 59 and 39 ends is indicated by *. Isolates that displayed human serum resistance, the classical T. b. gambiense isoenzyme profile and possess TgSGP
can be inferred to be group 1 T. b. gambiense (Red). Isolates that display a degree of resistance or were isolated from humans but did not possess the
classical isoenzyme profile or TgSGP were determined to be group 2 T. b gambiense (Blue). Strains that exhibited no human serum resistance and
were isolated from animals are most likely T. b. brucei (Black). b. Predicted structure of the Coˆte d’Ivoire T. brucei focus for the most likely population
number (K = 2). The proportion of each population that an isolate is a member of is indicated by red and blue in the histogram. c. Principal
component analysis (PCA) of the Coˆte d’Ivoire T. brucei isolates using a pair-wise genetic distance comparison between each isolates MLG. The x-axis
Human & Animal Trypanosome Popgen in Coˆte d’Ivoire
PLOS ONE | www.plosone.org 3 July 2013 | Volume 8 | Issue 7 | e67852
highly resistant (all of 5 rodents infected), intermediate or sub-
resistant (1–4 rodents were infected) or sensitive (none of 5 rodents
infected) (Table S1Table S1). They have also been typed as
classical gambiense (group 1) or non-gambiense by isoenzyme or
RFLP profiles [16,21]. All of these samples were collected from a
similar time period (1978–1983) and from a geographic area that
contains both groups of T. b. gambiense. This collection of isolates
allows the analysis of the sub-species genetics at this time point and
the elucidation of the relationships between them, especially those
between group 1 and 2 T. b. gambiense, which has implications for
the evolution of human infectivity traits.
Materials and Methods
Ethical Statement
Ethical approval for the human derived isolates in this study
have been previously published [16,17].
Isolate Library
The collection of 43 T. brucei isolates used for population
analysis was collected from a disease focus in Coˆte d’Ivoire that
encompasses the townships of Gagnoa, Vavoua, Daloa and
Bouafle´ [16,21] from a range of hosts, including humans, between
1978 and 1983 (Table 1) The townships are approximately 50km
to 90km apart. Samples were obtained as purified DNA or blood
spots from stabilates on FTA cards that were washed and prepared
as per the manufacturer’s instructions before analysis (Whatman).
The collection comprises both classical group 1 T. b. gambiense and
group 2 T. b. gambiense as identified by isoenzymes and RFLPs
[35,36], and also non-human infective T. b. brucei determined by
BIIT. A 5 rodent BIIT [37] was used to assess whether each isolate
possessed the potential for human infectivity [11]. In addition to
the main sample collection, the following reference isolates were
also included: the group 1 T. b. gambiense genome strain MHOM/
CI/86/DAL972 [27,38], the 2 T. b gambiense strain STIB386
(MHOM/CI/78/TH114/78E) (also included in the main collec-
tion [39]) used in the T. b. gambiense genetic map [27,38] and the
comprehensively studied group 1 T. b. gambiense strain MHOM/
CI/52/ELIANE were also included.
Genotyping
Samples were genotyped for population analysis using previ-
ously published nested PCR primers for eight microsatellite
markers; Ch1/18, Ch1/D2/7, Ch2/PLC, Ch2/5, Ch5/JS2,
Ch11/110, Ch3/IJ15/1 and Ch4/M12C12 [40]. The Ch4/
M12C12 marker proved to be monomorphic for these samples
and was excluded. Markers on the same chromosome are at
opposite ends of the chromosome to each other and are unlikely to
be linked [27]. All of the primers used to amplify the
microsatellites have been previously identified and verified for
both T. b. brucei and T. b. gambiense populations [41]. The PCR
conditions for each nested reaction were 95uC 50 secs, 55uC 50
secs and 65uC 60 secs, for 30 cycles. PCR was performed in a total
volume of 30 ml with the primers at a final concentration of 10 mM
each and Taq polymerase final concentration of 0.25 units/ml
(Thermo Scientific). If a sample was homozygous at a marker, it
was repeated, otherwise all reactions were performed once. To
determine allele size, one of the second round primers was tagged
using either AFAM or HEX fluorescent dye to allow accurate
sizing on a capillary ABI sequencer against ROX labeled size
standards (Dundee Sequencing Unit). The size of the tagged PCR
product was measured to within 2bp using the Peak ScannerH
software package (Applied Biosystems). Each distinct allele size was
given a number and the two alleles for each locus were catalogued
for each isolate. This allowed the creation of a multi-locus
genotype (MLG) for each isolate. In addition to the microsatellite
MLG, the samples were further characterized using the previously
published diagnostic PCR for the presence/absence of the TgSGP
gene [42,43] and an improved set of nested TgSGP primers that
span the 59 and 39 regions of the gene [44]. The PCR conditions
used for these primers were 95uC 50 secs, 55uC 50 secs and 65uC
120 secs, for 35 cycles. TgSGP PCR was performed in a total
volume of 10 ml.
Population Analysis
The multi-locus genotype (MLG) of each isolate studied was
used to create a dendrogram to infer relationships within the Coˆte
d’Ivoire T. brucei population. Clustering calculator (http://www.
biology.ualberta.ca/jbrzusto/cluster.php) was used to create a
Phylip Drawtree string (analysed using neighbor-joining clustering
and Canberra Distances). A bootstrap with 100 iterations was also
generated. This Drawtree string was then converted into a
dendrogram using Figtree software (http://tree.bio.ed.ac.uk/).
Heterozygosity, Nei’s genetic distance and FST were calculated
using the GenAlEx software package for Microsoft Excel [41].
Hardy-Weinberg calculations were also performed using GenAlEx
and linkage disequilibrium calculations were performed using
GenePop v4.0.10 [45–47] and LIAN v3.5 [47] software packages.
The likelihood of replicated genotypes occurring due to sexual
recombination was examined using MLGsim 2.0 [48], usingPsex
values calculated for each replicated MLG compared to 10,000
simulations for a population of the same size. Additionally, a
principal component analysis (PCA) of the genetic distance was
performed on the three populations using the GenAlEx software
package [41]. k-means clustering was calculated from the
eigenvalues from the PCA using the kmean() function of the R
software package [49]. Finally, a sub-structuring modeling analysis
was performed on the MLG using the STRUCTURE software
package [50]. The models were formulated assuming an
admixture model and correlated allele frequencies and a burn-in
explains 56.45% of the variability in the populations and the y-axis 13.98%, for a total of 70.45%. Isolates are colored as outlined in 1a. The circled
numbers indicate the centroids of the two clusters identified by k-means analysis. The limits of these clusters are also indicated.
doi:10.1371/journal.pone.0067852.g001
Table 2. Polymorphisms and heterozygosity of T. brucei at
the Coˆte d’Ivoire focus (N = 45).
Locus Alleles
Observed
Heterozygosity
Expected
Heterozygosity
Ch5/JS2 8 0.667 0.784
Ch11/110 3 0.200 0.182
Ch11/51 3 0.356 0.299
Ch1/18 8 0.867 0.656
Ch1/D2/7 8 0.267 0.709
Ch2/PLC 5 0.200 0.424
Ch3/IJ15/1 6 0.359 0.363
doi:10.1371/journal.pone.0067852.t002
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value of 50,000 and replication value of 250,000 [27,28]. Several
estimates of population size (K) were investigated for K=2 to 12.
The most likely estimate for K was inferred using both the
posterior probability of 5 repeat runs for each value of K
[40,51,52] and an estimate of delta K [40].
Results
All studies of the population structure of group 1 T. b. gambiense
to date have revealed foci to be largely clonal and relatively
homogeneous [40]. Isoenzymes and RFLP analyses suggest that
group 1 T. b. gambiense is genetically distinct from sympatric T. b.
brucei and from group 2 T. b. gambiense. Here we have examined
parasites isolated from both human patients and animals in four
neighboring foci of infection in the Coˆte d’Ivoire in the late 1978
and 1983. The samples can be segregated into three different
classes based on previous isoenzyme and RFLP studies and by the
ability to resist lysis by human serum measured using the BIIT.
Isolates that are invariably resistant to lysis and possess the classical
isoenzymes of T. b. gambiense are classified as group 1 T. b.
gambiense. A second group of parasites that also show resistance
(either by BIIT or due to being isolated from a human host) but
lack the isoenzyme markers characteristic of group 1 T. b.
gambiense, are defined as non-gambiense or group 2 T. b. gambiense.
Isoenzyme profiles of these isolates were highly variable [11]. The
third group of isolates were sensitive to human serum in the BIIT
and were not isolated from human patients; they were therefore
classified as T. b. brucei and the isoenzyme profiles of these isolates
were also highly variable [11].
TgSGP Genotyping
The cell surface receptor TgSGP has been proposed as a
diagnostic marker of group 1 T. b. gambiense [52] and PCR
targeting the 39 end of the gene was recommended to test for the
presence of the gene as a diagnostic for T. b. gambiense group 1 [52].
Unfortunately, several group 2 T. b. gambiense are also positive for
the published PCR diagnostic test, limiting its use in foci with both
groups of T. b. gambiense [40]. Further work has now shown that
the 39 end of the TgSGP gene is closely related to the VSG
Tb10.v4.0178 and this VSG is likely the progenitor of this section of
the TgSGP gene [47]. Tb10.v4.0178 is present in several strains,
including T. b brucei, T. b. rhodesiense and group 2 T. b. gambiense
isolates [27,28], so there is a possibility of false positives when
using the originally proposed primers. In our analysis using the
original primers targeted to the 39 end of the TgSGP gene [27,28],
21 isolates were positive for the TgSGP gene diagnostic, of which,
18 were previously characterized as group 1 T. b. gambiense on the
basis of isoenzymes and RFLPs. However, two isolates (MSUS/
CI/78/TSW209 and MSUS/CI/78/TSW158) that would be
putatively identified as group 2 T. b. gambiense on the basis of
human serum resistance phenotype in the BIIT but non-classical
isoenzyme profiles, also showed positive for the 39 end of the
TgSGP gene. Additionally, a serum sensitive isolate (MSUS/CI/
78/TSW308) was also positive. However, when using nested PCR
primers that span both the 59 and 39 regions of the gene, the
TgSGP gene was only shown to be present in the 18 isolates
previously identified as group 1 T. b. gambiense (Figure 1a). This
would suggest that the three non-group 1 T. b. gambiense isolates are
false positives and possess either VSG Tb10.v4.0178 or a closely
related VSG. To investigate the relationships between the isolates
from this disease focus, the isolates were further characterized
using microsatellite genotyping.
Microsatellite Genotyping
To investigate the relationships between the group 1 and 2 T. b.
gambiense and T. b. brucei populations, the genotype of each of the
45 samples was determined using seven microsatellite markers. All
seven markers are polymorphic, featuring several alleles at each
locus (Table S1). For the entire sampled population, the majority
of markers display a level of heterozygosity that is in in agreement
with Hardy-Weinberg distribution (Table 2). Using these multi-
locus genotypes (MLG), a dendrogram of relatedness was created
to visualize the relationship between isolates in the study (figure 1a).
The dendrogram revealed a discrete population containing only
the 18 isolates characterized as group 1 T. b. gambiense by
isoenzymes, RFLPs, BIIT and the presence of TgSGP. This clade
also included the genome reference strain MHOM/CI/86/
DAL972 and the well characterized group 1 strain MHOM/
CI/52/ELIANE. The bootstrap value (100) indicates a high
degree of support for the node that separates this group. The
Table 3. Nei’s genetic distance between the populations of group 1 and 2 T. b. gambiense and T. b. brucei at the Coˆte d’Ivoire
focus.
T. b. brucei (N=9) Gp 2 T. b. gambiense (N=16) Gp 1 T. b. gambiense (N=20)
T. b. brucei 0.000 – –
Gp 2 T. b. gambiense 0.026 0.000 –
Gp 1 T. b. gambiense 0.357 0.321 0.000
doi:10.1371/journal.pone.0067852.t003
Table 4. Fst proportion indicating genetic distance between the populations of group 1 and 2 T. b. gambiense and T. b. brucei at
the Coˆte d’Ivoire focus.
T. b. brucei (N=9) Gp 2 T. b. gambiense (N=16) Gp 1 T. b. gambiense (N=20)
T. b. brucei 0.000 – –
Gp 2 T. b. gambiense 0.138 0.000 –
Gp 1 T. b. gambiense 0.277 0.264 0.000
doi:10.1371/journal.pone.0067852.t004
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remaining 27 isolates formed a separate cluster distinct from the
group 1 T. b. gambiense, containing both serum sensitive T. b. brucei
(n = 9) and serum resistant group 2 T. b. gambiense isolates (n = 18).
There is little bootstrap support for any of the branching nodes
within this clade, suggesting this cluster represents a single
population and that T. b. brucei and group 2 T. b. gambiense are
largely indistinguishable from each other.
Principal components analysis (PCA) was performed using the
genetic distance of the isolates to create a multi-dimensional
comparison (figure 1c). PCA identifies the independent factors
from a data set that explain the maximum amount of correlation.
Plotting these factors allows the structure of a population to be
visualized. Further structure could be inferred by utilizing k-mean
clustering and the eigenvalues from the PCA. This identified two
distinct clusters; one containing T. b. brucei and group 2 T. b.
gambiense populations and a second containing only isolates
previously identified as group 1 T. b. gambiense. When analyzed
by village, there is no evidence for any sub-structuring in the group
2 and T. b. brucei populations based on geography (data not shown)
suggesting that the parasites within the townships are part of the
same transmission cycle. Also, while not included in the analysis
due to low sample numbers, similar genotypes are present in group
2 T. b. gambiense and T. b. brucei isolates from neighboring Burkina
Faso, suggesting that there is one meta-population spanning the
two countries (Table S1).
In order to further examine the population structure of the Coˆte
d’Ivoire focus, STRUCTURE modeling was performed using the
MLG data set. The most likely population number (K) was found
to be 2 when estimated using both posterior probabilities and delta
K (figure 1b) [47]. Isolates are either predominantly a member of a
population containing only group 1 T. b. gambiense or a population
containing group 2 T. b. gambiense and T. b. brucei. The removal of
the group 1 isolates and then re-modeling with STRUCTURE did
not indicate any further structure in the T. b. brucei/group 2 T. b.
gambiense isolates (up to K=12, data not shown).
Population Analysis
In order to determine the population structure within each
clearly distinct cluster as defined by the dendrogram, PCA and
STRUCTURE, each cluster was examined separately. Cluster 1
contained the 18 isolates that had previously been identified as
group 1 T. b. gambiense isolates and have subsequently been shown
to all possess TgSGP. Cluster 2 contained all other isolates (n = 27),
i.e. serum sensitive T. b. brucei and the non-classical gambiense
isolates that showed any degree of serum resistance and could be
termed group 2 T. b. gambiense. To further examine the differences
between the sub-species and groups, cluster 2 was sub-divided into
those isolates that previously showed any degree of resistance in a
BIIT (putative group 2 T. b. gambiense, n = 18) and those that were
highly sensitive and could be described as T. b. brucei isolates
(n = 9).
The relationship between these populations was analyzed using
two statistical tests, Nei’s genetic distance and FST. Both Nei’s
genetic distance and the FST statistic indicate that both popula-
tions within cluster 2 are distinct from cluster 1 and that within
cluster 2, there is very little genetic difference between T. b. brucei
and group 2 T. b. gambiense populations (Tables 3 & 4). As there is
so little difference between populations, subsequent analysis
considered the cluster 2 as a single population.
If random mating is occurring within the Coˆte d’Ivoire
population then the number of heterozygous genotypes within
the population should be a predictable proportion based on the
number and frequency of alleles present in the population, in
agreement with Hardy-Weinberg expectations. Analysis of the
genotype frequencies in cluster 2 (the combined T. b. brucei and
group 2 T. b. gambiense isolates) revealed that none of the seven
markers significantly deviated from Hardy-Weinberg equilibrium
(Table 5). These data are consistent with the hypothesis that some
degree of mating is occurring within this cluster i.e. within and
between the group 2 T. b. gambiense and T. b. brucei. In contrast,
analysis of markers for cluster 1 shows that the group 1 T. b.
gambiense population display a strong deviation from Hardy-
Weinberg, with markers being either monomorphic or possessing
heterozygote excess strongly disagreeing with the Hardy-Weinberg
hypothesis (Table 6).
A second method to assess the degree of mating within cluster 2
is to estimate the amount of linkage disequilibrium in allele and
genotype frequencies. The presence of mating in a population will
cause alleles at unlinked loci to be inherited in a randomly assorted
manner, leading to linkage equilibrium, while a population with
little mating will exhibit linkage disequilibrium. Analysis of linkage
equilibrium revealed that the overwhelming majority of allele
combinations do not show significant linkage disequilibrium in
cluster 2 (Table 7). Additionally, both the T. b. brucei and group 2
T. b. gambiense populations exhibit a standardized Index of
Association (IA) that tends towards zero. IA s a function of the
rate of recombination and is zero for complete linkage equilibri-
um, so our data are consistent with linkage equilibrium existing in
these populations (Table 8). Linkage equilibrium is also exhibited
when the T. b. brucei and group 2 populations are analyzed
together, suggesting linkage equilibrium between the populations.
These data, combined with the Hardy-Weinberg analysis suggest
that there is a degree of mating and re-assortment both between
and within the T. b. brucei and group 2 T. b. gambiense populations.
The group 1 T. b. gambiense alleles are largely monomorphic or
uninformative so a linkage disequilibrium study is not possible with
this population. However the low number of alleles and limited
variability correlates with studies of other foci, suggesting that
group 1 T. b. gambiense possesses a clonal population structure that
is separate from that of the group 2 T. b. gambiense and T. b. brucei
population [27,28]. The low variability in genotypes of the group 1
T. b. gambiense isolates were tested for clonality using MLGsim.
This indicated that all observed Psex values for each MLG
expansion were highly significant at the p,0.01 threshold,
suggesting that all of the samples are clonal. Conversely, the same
analysis on the T. b. brucei and group 2 T. b. gambiense populations
shows that most genotypes have likely arisen due to sexual
recombination and only two of the samples possess possible clonal
genotypes at the p,0.01 significance threshold, MSUS/CI/78/
TSW158 and MSUS/CI/78/TSW175.
It would appear from these data that the T. b. brucei and group 2
T. b. gambiense populations exhibit some degree of mating, both
within and between sub-species. The group 1 T. b. gambiense
population is clonal and distinct from the sympatric T. b. brucei and
group 2 T. b gambiense populations.
Discussion
These data reinforce studies from other foci that populations of
group 1 T. b. gambiense are likely clonal [27,28]. The reasons for the
clonality of group 1 T. b. gambiense are unclear as the genes
necessary for meiosis are present [37] and are expressed during
tsetse infection (Peacock and Gibson, unpublished data). Another
possible reason for the low frequency of mating observed in group
1 T. b. gambiense is that, due to the limited number of genotypes
present, the chances of a mixed genotype infection occurring in
the tsetse vector is unlikely. This precludes any mating other than
selfing, which has been observed in laboratory crosses for T. b.
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brucei [53]. However a high frequency of selfing would result in a
population with an excess of homozygotes rather than the
observed excess of heterozygotes, and is therefore unlikely.
The observed homogeneous population of group 1 T. b.
gambiense could also be due to a bottleneck effect that occurred in
the past or if group 1 T. b. gambiense underwent clonal expansion,
possibly after it gained the human infectivity trait. Despite
questions as to how the clonal population structure has developed,
these data show that the group 1 T. b. gambiense genome reference
strain MHOM/CI/86/DAL972 is clearly a good representative of
group 1 strains from this area. Previous studies have shown that
the MLG in the populations of various group 1 T. b. gambiense foci
are significantly different from each other [27] and examination of
the microsatellite alleles in this study with previous studies
indicates that there are few shared alleles at each marker. Indeed,
the necessity to include new markers specific to this study
reinforces the fact that the focus possesses a different clonal
population of group 1 T. b. gambiense to that found in other foci.
This study has also shown that the STIB386 strain (MHOM/
CI/78/TH114) used in genetic mapping studies [54] is a good
representative for Coˆte d’Ivoire group 2 T. b. gambiense in that it is
distinct from the group 1 T. b. gambiense population and clusters
with other group 2 T. b. gambiense strains. Previous studies have
suggested that group 2 T. b. gambiense are more varied than group 1
and more similar to T. b. brucei [16,19,22–26]. The data presented
here show that not only was there a large and genetically varied
breeding population of group 2 T. b. gambiense at the Coˆte d’Ivoire
focus, that these individuals were almost certainly breeding with
local T. b. brucei. The T. b. brucei and group 2 T. b. gambiense
populations are very similar, suggesting that they form one
breeding population. There is a suggestion that this breeding
population extends to neighboring Burkina Faso, as similar
microsatellite alleles are found in both countries. However, this
may be due to the seasonal, economic migration of the Mossi
people between the two nations [55] that transports parasites
rather then a large contiguous population. Nevertheless, group 2
T. b. gambiense can be seen as an extended host range variant T. b.
brucei.
The degree to which mating occurs in a population is an
important consideration due to the process acting as a major
source of variation. While the human infectivity trait present in
group 2 T. b. gambiense may have evolved once, it is now present in
a wide range of genetic backgrounds. This is in contrast to group 1
T. b. gambiense which has limited genetic diversity at each discrete
disease focus and hence a lower capacity to evolve. The genetic
backgrounds of the group 2 T. b. gambiense infectivity trait may be
in constant flux due to evidence suggesting the presence of mating
within the population. This may go someway to explaining the
emergence of a ‘‘new’’ group of T. b. gambiense in Coˆte d’Ivoire
[56]. This new human infective group has been claimed as distinct
from both group 1 T. b. gambiense and group 2 T. b. gambiense from
the early 1980s. However, based on the heterogeneity and
propensity for mating displayed by group 2 in our study, it is
likely that this new group belongs to group 2, with the group 2
human serum resistance mechanism on a new genetic background.
Unfortunately, the human serum resistance profile of the new
group has not yet been described and it is unknown whether it also
Table 5. Hardy-Weinberg analysis for the combined
population of group 2 T. b. gambiense and T. b. brucei at the
Coˆte d’Ivoire focus (N= 25).
Locus DF x2 Probability Significance
Ch5/JS2 15 21.021 0.136 Not Significant
Ch11/110 3 1.080 0.782 Not Significant
Ch11/51 3 0.173 0.982 Not Significant
Ch1/18 15 18.798 0.223 Not Significant
Ch1/D2/7 6 6.762 0.343 Not Significant
Ch2/PLC 10 15.693 0.109 Not Significant
Ch3/IJ15/1 6 6.832 0.559 Not Significant
doi:10.1371/journal.pone.0067852.t005
Table 6. Hardy-Weinberg analysis of group 1 T. b. gambiense
isolates at the Coˆte d’Ivoire focus (N= 20).
Locus DF x2 Probability Significance
Ch5/JS2 3 18.000 0.000 P,0.001
Ch11/110 Monomorphic – – –
Ch11/51 1 4.500 0.034 P,0.05
Ch1/18 1 18.000 0.000 P,0.001
Ch1/D2/7 6 18.147 0.006 P,0.001
Ch2/PLC 1 0.015 0.904 Not Significant
Ch3/IJ15/1 Monomorphic – – –
doi:10.1371/journal.pone.0067852.t006
Table 7. Linkage disequilibrium for each genetic marker
(statistically significant disequilibrium highlighted in bold)
between pair wise polymorphic loci in the combined T. b.
brucei and group 2 T. b. gambiense population at the Coˆte
d’Ivoire focus (N = 25).
Locus 1 Locus 2 Probability Standard Error
Ch5/JS2 Ch11/110 0.345 0.014
Ch5/JS2 Ch11/51 0.053 0.006
Ch11/110 Ch11/51 1.000 0.000
Ch5/JS2 Ch1/18 0.299 0.029
Ch11/110 Ch1/18 0.136 0.008
Ch11/51 Ch1/18 0.410 0.012
Ch5/JS2 Ch1/D2/7 0.172 0.019
Ch11/110 Ch1/D2/7 0.351 0.009
Ch11/51 Ch1/D2/7 1.000 0.000
Ch1/18 Ch1/D2/7 0.040 0.008
Ch5/JS2 Ch2/PLC 0.081 0.012
Ch11/110 Ch2/PLC 0.648 0.003
Ch11/51 Ch2/PLC 0.573 0.018
Ch1/18 Ch2/PLC 0.007 0.032
Ch1/D2/7 Ch2/PLC 0.293 0.010
Ch5/JS2 Ch3/IJ15/1 0.373 0.015
Ch11/110 Ch3/IJ15/1 0.237 0.022
Ch11/51 Ch3/IJ15/1 0.363 0.021
Ch1/18 Ch3/IJ15/1 0.721 0.023
Ch1/D2/7 Ch3/IJ15/1 0.274 0.011
Ch2/PLC Ch3/IJ15/1 0.525 0.021
The data were analyzed using the Genepop 4.0 software package.
doi:10.1371/journal.pone.0067852.t007
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displays a variable, non-SRA mediated resistance [56]. Elucidation
of the resistance mechanism for group 2 T. b. gambiense would also
allow this hypothesis to be investigated.
A previous microsatellite study has indicated that although
group 2 T. b. gambiense from Coˆte d’Ivoire is related to T. b. brucei, it
also clusters close to group 1 T. b. gambiense [29]. This has led to the
suggestion it is a hybrid of T. b. brucei and group 1 T. b. gambiense.
However, the T. b. brucei used in the study were mostly from East
Africa and are not be representative of T. b. brucei in Coˆte d’Ivoire.
Our data clearly shows that the West African T. b. brucei and group
2 T. b. gambiense populations are largely indistinguishable and that
group 2 is not closer to group 1 T. b. gambiense than local T. b.
brucei. There is no evidence to support the hypothesis that group 2
T. b. gambiense is a hybrid of group 1 T. b. gambiense and T. b. brucei
and that this sub-species has evolved separately. We have also
shown that TgSGP is not present in the local group 2 T. b. gambiense
or T. b. brucei populations by using nested primers that span the 59
and 39 ends of the gene. While this is counter to other published
data [40], the primers described in the original diagnostic PCR are
likely to show false positives due to similarity to the 39 end of
TgSGP and the VSG Tb10.v4.0178 [52]. This observation adds
further weight to the hypothesis that there is no mating between
group 1 or group 2 T. b. gambiense, and that group 2 has not
emerged as a result of hybridizing event.
The study presented here, in conjunction with other published
data, suggests that human infectivity has arisen on at least three
occasions (with some evidence of a fourth variant). In East Africa
the evolution of SRA and the high levels of mating occurring there
have allowed the human infectivity trait to spread through the T.
brucei population, generating the T. b. rhodesiense sub-species
[57,58]. However, there are also human infective trypanosomes
in this area that do not possess SRA, suggesting a second novel
mechanism [3,59]. In West and Central Africa, group 1 T. b.
gambiense is the dominant cause of human African sleeping sickness.
This group of parasites has evolved a constitutively expressed
human serum resistance mechanism that does not depend on SRA.
After evolution of this trait, the sub-species appears to have
expanded clonally in the human population. Just as in East Africa,
there is also a human infective T. brucei population separate from
the dominant form that appears to have a novel resistance
mechanism. This group 2 T. b. gambiense population appears to be
a host range variant of T. b. brucei and the human infectivity trait it
possesses is freely transmitted among the local T. b. brucei
population. The presence of mating amongst group 2 T. b.
gambiense and T. b. brucei strains makes evolution of new traits more
likely and may allow the human infectivity trait to be combined
with new phenotypes that may increase its virulence. It also allows
the human resistance trait to persist in the local T. brucei animal
reservoir through genetic transfer. Understanding whether the
inter-sub-species mating and transfer of human infectivity traits
exhibited in Coˆte d’Ivoire can also occur in other foci is becoming
more pressing. In Uganda, the T. b. gambiense and T. b. rhodesiense
foci are moving closer together and their ranges will begin to
overlap [60,61]. Fortunately the possibility of mating between
group 1 T. b. gambiense and T. b. rhodesiense appears unlikely due to
the clonal nature of group 1 T. b gambiense [27,28], and while T. b.
rhodesiense mating with group 2 T. b. gambiense is certainly possible
[33], the ranges of these two diseases are not converging at
present. Taken together, all of these data indicate that T. brucei has
a high zoonotic potential despite specific trypanolytic counter-
measures that have been inherited by humans.
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